US Patent 7101971 Erythropoietin analog-human serum albumin fusion

Patent 7101971 was granted and assigned to GTC BIOTHERAPEUTICS, INC. on September, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

GTC BIOTHERAPEUTICS, INC.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

71019710

Patent Inventor Names

Michael Young0

Harry M. Meade0

Ian Krane0

Date of Patent

September 5, 2006

Patent Application Number

100814000

Date Filed

February 20, 2002

Patent Primary Examiner

‌

Joseph Woitach

Patent abstract

Erythropoietin analog-human serum albumin (EPOa-hSA) fusion protein and methods of making and using the fusion protein.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7101971 Erythropoietin analog-human serum albumin fusion

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API